These results highlight retatrutide potential beyond weight management alone
Weight Loss Results: What the Clinical Data Shows Clinical trial results provide the clearest comparison point between these two compounds
By the studys end, patients in all three tirzepatide groups lost around 4-12 more pounds than the semaglutide group and exhibited better diabetic biomarkers.3 The second was published in JAMA Internal Medicine in 2024
[4] [2] Abdominal distension specifically was reported in clinical trials, though at lower rates than nausea or diarrhea
It is currently advancing through Phase 3 clinical trials for obesity treatment
1 Beyond that, smaller portions, lean protein, lighter meals after injection, good hydration, and movement after meals all help